COVID-19: Herd immunity and convalescent plasma transfer therapy

J Med Virol. 2020 Sep;92(9):1380-1382. doi: 10.1002/jmv.25870. Epub 2020 Jul 11.

Abstract

Coronavirus disease 2019 (COVID‐19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), has spread worldwide triggering a pandemic. Its first case was reported in Wuhan, the capital of China's Hubei province, and since then it has spread across world becoming one of the worst pandemics in the history of mankind1. Its basic reproductive number (R0) has been determined to be 2‐32.

This article is protected by copyright. All rights reserved.

MeSH terms

  • COVID-19 / immunology*
  • COVID-19 / therapy*
  • Humans
  • Immunity, Herd*
  • Immunization, Passive

Supplementary concepts

  • COVID-19 serotherapy